Evidence map›Paper›PMID 33686068›Full record

ArticleNature communications2021

Hyperproduction of 3-hydroxypropionate by Halomonas bluephagenesis.

Xiao-Ran Jiang, Xu Yan, Lin-Ping Yu, Xin-Yi Liu, Guo-Qiang Chen

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Article
  3. EngineeringBiomolecules · 2026
    Article
  4. Metabolic engineering enablesSynthetic and systems biotechnology · 2026
    Article
  5. An Efficient COAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Decoding metabolic trade-offs inSynthetic and systems biotechnology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. EngineeringSynthetic and systems biotechnology · 2024
    Article
  14. Simultaneous multiplex genome loci editing ofSynthetic and systems biotechnology · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. EngineeringFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xiao-Ran Jiang *Department of Microbiology, Army Medical University, Chongqing, China.
Xu Yan *School of Life Sciences, Tsinghua University, Beijing, China.
Lin-Ping YuSchool of Life Sciences, Tsinghua University, Beijing, China.
Xin-Yi LiuSchool of Life Sciences, Tsinghua University, Beijing, China.ORCID http://orcid.org/0000-0003-1374-5178
Guo-Qiang ChenSchool of Life Sciences, Tsinghua University, Beijing, China. chengq@mail.tsinghua.edu.cn.ORCID http://orcid.org/0000-0002-7226-1782
Tsinghua University · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3-Hydroxypropionic acid (3HP), an important three carbon (C3) chemical, is designated as one of the top platform chemicals with an urgent need for improved industrial production. Halomonas bluephagenesis shows the potential as a chassis for competitive bioproduction of various chemicals due to its ability to grow under an open, unsterile and continuous process. Here, we report the strategy for producing 3HP and its copolymer poly(3-hydroxybutyrate-co-3-hydroxypropionate) (P3HB3HP) by the development of H. bluephagenesis. The transcriptome analysis reveals its 3HP degradation and synthesis pathways involving endogenous synthetic enzymes from 1,3-propanediol. Combing the optimized expression of aldehyde dehydrogenase (AldD

Indexed as

Biosynthetic PathwaysMetabolic EngineeringBacterial ProteinsBiopolymersGene EditingGene Expression Regulation, BacterialHalomonasHydroxybutyratesLactic AcidPolyestersPropylene Glycols1,3-propanediolBacterial ProteinsBiopolymershydracrylic acidHydroxybutyratesLactic AcidPolyestersPropylene Glycols

Identifiers

PMID33686068
PMCPMC7940609
OpenAlexW3135711990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.